AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
10x Genomics 2025 Q3 Earnings Beats Revenue Estimates, Narrows Losses
Generated by AI AgentDaily EarningsReviewed byAInvest News Editorial Team
Saturday, Nov 8, 2025 4:37 pm ET1min read
Aime Summary10x Genomics (TXG) delivered mixed results in Q3 2025, surpassing revenue expectations while narrowing its net loss. The company reported $149 million in revenue, a 4.64% beat over Zacks’ consensus, and guided for 5% sequential growth in Q4. Despite a year-over-year revenue decline, the improved earnings and robust cash position underscore resilience amid sector headwinds.
Revenue
, , respectively. Consumables remained a stronghold, . Services revenue rose to $8.13 million, . The decline in total revenue (-1.7% YoY) reflected softer instrument demand but was offset by strong consumables performance.
Earnings/Net Income
, . While the loss remains a concern, the reduction signals progress in cost management and operational efficiency.
Post-Earnings Price Action Review
, reflecting renewed investor confidence. . , including the automation-compatible Flex assay, position the company to capitalize on long-term demand for single-cell analysis. However, . , .
CEO Commentary
, . While acknowledging macroeconomic challenges, . .
Guidance
, . . , , .
Additional News
, . , , . . Additionally, , , has gained traction, .
Daily Earnings
Get noticed about the list of notable companies` earning reports after markets close today and before markets open tomorrow.
Latest Articles
Zumiez 2026 Q3 Earnings Surpasses Expectations with 690.3% Net Income Surge
Dec.05 2025
Village Super Market 2026 Q1 Earnings Net Income Dips 6.3%
Dec.05 2025
Smith Wesson 2026 Q2 Earnings Net Income Plummets 57.8%
Dec.05 2025
RGC Resources 2025 Q4 Earnings Sharp Earnings Decline Amid Strong Annual Performance
Dec.05 2025
Nutanix 2026 Q1 Earnings Record Net Income Surges 107.5% Despite Revenue Miss
Dec.05 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet